JGECX
Price
$12.14
Change
-$0.01 (-0.08%)
Updated
May 22 closing price
Net Assets
731.05M
VGPMX
Price
$14.83
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Net Assets
1.61B
Interact to see
Advertisement

JGECX vs VGPMX

Header iconJGECX vs VGPMX Comparison
Open Charts JGECX vs VGPMXBanner chart's image
JHancock Global Equity C
Price$12.14
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets731.05M
Vanguard Global Capital Cycles Investor
Price$14.83
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets1.61B
JGECX vs VGPMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JGECX vs. VGPMX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGECX is a Buy and VGPMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGPMX has more cash in the bank: 1.61B vs. JGECX (731M). VGPMX pays higher dividends than JGECX: VGPMX (2.24) vs JGECX (0.22). JGECX was incepted earlier than VGPMX: JGECX (10 years) vs VGPMX (41 years). JGECX (2.01) is less costly to investors than VGPMX (0.44). JGECX is a more actively managed with annual turnover of: 36.00 vs. VGPMX (32.00). JGECX has a lower initial minimum investment than VGPMX: JGECX (1000) vs VGPMX (3000). VGPMX annual gain was more profitable for investors over the last year : 10.16 vs. JGECX (-7.61). VGPMX return over 5 years is better than : 110.36 vs. JGECX (16.42).
JGECXVGPMXJGECX / VGPMX
Total Expense Ratio2.000.44455%
Annual Report Gross Expense Ratio2.010.44457%
Fund Existence10 years41 years-
Gain YTD4.29217.43025%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets731M1.61B45%
Annual Yield % from dividends0.222.2410%
Returns for 1 year-7.6110.16-75%
Returns for 3 years7.0427.6125%
Returns for 5 years16.42110.3615%
Returns for 10 years11.4060.7519%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDTC2.250.15
+7.14%
CytoMed Therapeutics Limited
BXC66.510.42
+0.64%
BlueLinx Holdings
SGHT3.24N/A
N/A
Sight Sciences
PCVX33.95-0.02
-0.06%
Vaxcyte
HEI267.08-1.76
-0.65%
HEICO Corp